nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Cladribine—multiple sclerosis	0.0923	0.146	CbGbCtD
Venlafaxine—ABCG2—Mitoxantrone—multiple sclerosis	0.0674	0.107	CbGbCtD
Venlafaxine—CYP2D6—Fingolimod—multiple sclerosis	0.0487	0.0772	CbGbCtD
Venlafaxine—ABCG2—Dexamethasone—multiple sclerosis	0.0349	0.0554	CbGbCtD
Venlafaxine—ABCB1—Methylprednisolone—multiple sclerosis	0.0333	0.0528	CbGbCtD
Venlafaxine—CYP3A4—Fingolimod—multiple sclerosis	0.031	0.0491	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—multiple sclerosis	0.0281	0.0445	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—multiple sclerosis	0.025	0.0396	CbGbCtD
Venlafaxine—CYP2B6—Dexamethasone—multiple sclerosis	0.0246	0.0389	CbGbCtD
Venlafaxine—ABCB1—Mitoxantrone—multiple sclerosis	0.0243	0.0385	CbGbCtD
Venlafaxine—ABCB1—Betamethasone—multiple sclerosis	0.0216	0.0343	CbGbCtD
Venlafaxine—ABCB1—Prednisolone—multiple sclerosis	0.0214	0.0339	CbGbCtD
Venlafaxine—ABCB1—Prednisone—multiple sclerosis	0.0202	0.032	CbGbCtD
Venlafaxine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0199	0.0316	CbGbCtD
Venlafaxine—CYP2C19—Dexamethasone—multiple sclerosis	0.0156	0.0247	CbGbCtD
Venlafaxine—CYP3A4—Triamcinolone—multiple sclerosis	0.0151	0.024	CbGbCtD
Venlafaxine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0146	0.0231	CbGbCtD
Venlafaxine—CYP2C9—Dexamethasone—multiple sclerosis	0.013	0.0206	CbGbCtD
Venlafaxine—CYP3A4—Betamethasone—multiple sclerosis	0.013	0.0206	CbGbCtD
Venlafaxine—CYP3A4—Prednisolone—multiple sclerosis	0.0128	0.0203	CbGbCtD
Venlafaxine—ABCB1—Dexamethasone—multiple sclerosis	0.0126	0.02	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—multiple sclerosis	0.0121	0.0192	CbGbCtD
Venlafaxine—CYP2D6—Dexamethasone—multiple sclerosis	0.0119	0.0188	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—multiple sclerosis	0.0101	0.016	CbGbCtD
Venlafaxine—CYP3A4—Dexamethasone—multiple sclerosis	0.00755	0.012	CbGbCtD
Venlafaxine—NPY1R—nerve—multiple sclerosis	0.00591	0.19	CbGeAlD
Venlafaxine—SLC6A3—nerve—multiple sclerosis	0.00249	0.0798	CbGeAlD
Venlafaxine—SLC6A2—nerve—multiple sclerosis	0.00201	0.0644	CbGeAlD
Venlafaxine—Cyclopentolate—BCHE—multiple sclerosis	0.00192	1	CrCbGaD
Venlafaxine—NPY1R—nervous system—multiple sclerosis	0.00133	0.0426	CbGeAlD
Venlafaxine—NPY1R—central nervous system—multiple sclerosis	0.00128	0.0411	CbGeAlD
Venlafaxine—SLC6A3—brainstem—multiple sclerosis	0.00107	0.0342	CbGeAlD
Venlafaxine—NPY1R—brain—multiple sclerosis	0.00102	0.0326	CbGeAlD
Venlafaxine—SLC6A4—brainstem—multiple sclerosis	0.000978	0.0314	CbGeAlD
Venlafaxine—SLC6A2—brainstem—multiple sclerosis	0.000861	0.0276	CbGeAlD
Venlafaxine—SLC6A3—midbrain—multiple sclerosis	0.00068	0.0218	CbGeAlD
Venlafaxine—SLC6A3—spinal cord—multiple sclerosis	0.000664	0.0213	CbGeAlD
Venlafaxine—SLC6A4—midbrain—multiple sclerosis	0.000623	0.02	CbGeAlD
Venlafaxine—SLC6A4—spinal cord—multiple sclerosis	0.000608	0.0195	CbGeAlD
Venlafaxine—SLC6A2—medulla oblongata—multiple sclerosis	0.0006	0.0193	CbGeAlD
Venlafaxine—SLC6A3—nervous system—multiple sclerosis	0.000559	0.0179	CbGeAlD
Venlafaxine—SLC6A3—central nervous system—multiple sclerosis	0.000538	0.0173	CbGeAlD
Venlafaxine—SLC6A3—cerebellum—multiple sclerosis	0.000526	0.0169	CbGeAlD
Venlafaxine—SLC6A4—nervous system—multiple sclerosis	0.000512	0.0164	CbGeAlD
Venlafaxine—SLC6A4—central nervous system—multiple sclerosis	0.000493	0.0158	CbGeAlD
Venlafaxine—ABCG2—medulla oblongata—multiple sclerosis	0.00048	0.0154	CbGeAlD
Venlafaxine—CYP2D6—brainstem—multiple sclerosis	0.000471	0.0151	CbGeAlD
Venlafaxine—SLC6A2—nervous system—multiple sclerosis	0.000451	0.0145	CbGeAlD
Venlafaxine—ABCG2—midbrain—multiple sclerosis	0.000438	0.0141	CbGeAlD
Venlafaxine—SLC6A2—central nervous system—multiple sclerosis	0.000434	0.0139	CbGeAlD
Venlafaxine—ABCG2—spinal cord—multiple sclerosis	0.000428	0.0137	CbGeAlD
Venlafaxine—SLC6A3—brain—multiple sclerosis	0.000427	0.0137	CbGeAlD
Venlafaxine—SLC6A4—brain—multiple sclerosis	0.000392	0.0126	CbGeAlD
Venlafaxine—SLC6A2—brain—multiple sclerosis	0.000345	0.0111	CbGeAlD
Venlafaxine—ABCG2—cerebellum—multiple sclerosis	0.000339	0.0109	CbGeAlD
Venlafaxine—CYP2B6—nervous system—multiple sclerosis	0.000332	0.0107	CbGeAlD
Venlafaxine—ABCB1—retina—multiple sclerosis	0.000327	0.0105	CbGeAlD
Venlafaxine—CYP2B6—central nervous system—multiple sclerosis	0.00032	0.0103	CbGeAlD
Venlafaxine—ABCG2—brain—multiple sclerosis	0.000275	0.00884	CbGeAlD
Venlafaxine—CYP2B6—brain—multiple sclerosis	0.000254	0.00815	CbGeAlD
Venlafaxine—CYP3A4—nervous system—multiple sclerosis	0.000251	0.00805	CbGeAlD
Venlafaxine—CYP2D6—nervous system—multiple sclerosis	0.000247	0.00793	CbGeAlD
Venlafaxine—CYP3A4—central nervous system—multiple sclerosis	0.000242	0.00775	CbGeAlD
Venlafaxine—CYP2D6—central nervous system—multiple sclerosis	0.000238	0.00763	CbGeAlD
Venlafaxine—ABCB1—medulla oblongata—multiple sclerosis	0.000236	0.00759	CbGeAlD
Venlafaxine—CYP2D6—cerebellum—multiple sclerosis	0.000232	0.00746	CbGeAlD
Venlafaxine—ABCB1—midbrain—multiple sclerosis	0.000216	0.00694	CbGeAlD
Venlafaxine—ABCB1—spinal cord—multiple sclerosis	0.000211	0.00677	CbGeAlD
Venlafaxine—CYP2D6—brain—multiple sclerosis	0.000189	0.00606	CbGeAlD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL13—multiple sclerosis	0.000183	0.0026	CbGpPWpGaD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000181	0.00257	CbGpPWpGaD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000181	0.00256	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.00018	0.00254	CbGpPWpGaD
Venlafaxine—ABCB1—nervous system—multiple sclerosis	0.000178	0.0057	CbGeAlD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—multiple sclerosis	0.000171	0.00242	CbGpPWpGaD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.000171	0.00242	CbGpPWpGaD
Venlafaxine—ABCB1—central nervous system—multiple sclerosis	0.000171	0.00549	CbGeAlD
Venlafaxine—NPY1R—Signaling Pathways—TAGAP—multiple sclerosis	0.000168	0.00238	CbGpPWpGaD
Venlafaxine—ABCB1—cerebellum—multiple sclerosis	0.000167	0.00537	CbGeAlD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000166	0.00235	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000166	0.00235	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000166	0.00235	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL5—multiple sclerosis	0.000165	0.00233	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000164	0.00232	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000164	0.00232	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000163	0.00231	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000154	0.00219	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000153	0.00216	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000153	0.00216	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000152	0.00216	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000152	0.00215	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000151	0.00214	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000151	0.00214	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000151	0.00213	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000151	0.00213	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000151	0.00213	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000149	0.00211	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000149	0.00211	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000149	0.00211	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCR5—multiple sclerosis	0.000148	0.0021	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000147	0.00209	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—S1PR1—multiple sclerosis	0.000147	0.00208	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000145	0.00205	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GPC5—multiple sclerosis	0.000143	0.00202	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000141	0.002	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000138	0.00196	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000137	0.00195	CbGpPWpGaD
Venlafaxine—ABCB1—brain—multiple sclerosis	0.000136	0.00436	CbGeAlD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000134	0.00189	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000134	0.00189	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000132	0.00186	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL3—multiple sclerosis	0.000131	0.00185	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.00013	0.00185	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR2—multiple sclerosis	0.00013	0.00184	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000128	0.00181	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000126	0.00178	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PTGER4—multiple sclerosis	0.000126	0.00178	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000125	0.00178	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RGS1—multiple sclerosis	0.000125	0.00177	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000124	0.00175	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCR3—multiple sclerosis	0.000121	0.00172	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CNR1—multiple sclerosis	0.00012	0.0017	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00012	0.00169	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GPR65—multiple sclerosis	0.000118	0.00168	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCR2—multiple sclerosis	0.000118	0.00167	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000118	0.00167	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—POMC—multiple sclerosis	0.000116	0.00164	CbGpPWpGaD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000115	0.00163	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL2—multiple sclerosis	0.000113	0.00161	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000113	0.0016	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00011	0.00155	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CNR1—multiple sclerosis	0.000109	0.00154	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000109	0.00154	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL13—multiple sclerosis	0.000108	0.00153	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCR1—multiple sclerosis	0.000108	0.00153	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000108	0.00153	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—FAS—multiple sclerosis	0.000108	0.00153	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000106	0.00151	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000102	0.00144	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.99e-05	0.00141	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.99e-05	0.00141	CbGpPWpGaD
Venlafaxine—Vertigo—Betamethasone—multiple sclerosis	9.87e-05	0.000372	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	9.86e-05	0.000371	CcSEcCtD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.85e-05	0.00139	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.85e-05	0.00139	CbGpPWpGaD
Venlafaxine—Syncope—Dexamethasone—multiple sclerosis	9.85e-05	0.000371	CcSEcCtD
Venlafaxine—Syncope—Betamethasone—multiple sclerosis	9.85e-05	0.000371	CcSEcCtD
Venlafaxine—Arrhythmia—Prednisone—multiple sclerosis	9.82e-05	0.00037	CcSEcCtD
Venlafaxine—Infection—Triamcinolone—multiple sclerosis	9.82e-05	0.00037	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL10—multiple sclerosis	9.82e-05	0.00139	CbGpPWpGaD
Venlafaxine—Sweating—Methotrexate—multiple sclerosis	9.81e-05	0.00037	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.81e-05	0.00139	CbGpPWpGaD
Venlafaxine—Infection—Methylprednisolone—multiple sclerosis	9.8e-05	0.000369	CcSEcCtD
Venlafaxine—Haematuria—Methotrexate—multiple sclerosis	9.76e-05	0.000368	CcSEcCtD
Venlafaxine—Shock—Triamcinolone—multiple sclerosis	9.72e-05	0.000366	CcSEcCtD
Venlafaxine—Insomnia—Prednisolone—multiple sclerosis	9.72e-05	0.000366	CcSEcCtD
Venlafaxine—Alopecia—Prednisone—multiple sclerosis	9.71e-05	0.000366	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.71e-05	0.00137	CbGpPWpGaD
Venlafaxine—Shock—Methylprednisolone—multiple sclerosis	9.7e-05	0.000365	CcSEcCtD
Venlafaxine—Loss of consciousness—Betamethasone—multiple sclerosis	9.66e-05	0.000364	CcSEcCtD
Venlafaxine—Loss of consciousness—Dexamethasone—multiple sclerosis	9.66e-05	0.000364	CcSEcCtD
Venlafaxine—Epistaxis—Methotrexate—multiple sclerosis	9.65e-05	0.000364	CcSEcCtD
Venlafaxine—Hypersensitivity—Mitoxantrone—multiple sclerosis	9.65e-05	0.000364	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisolone—multiple sclerosis	9.65e-05	0.000363	CcSEcCtD
Venlafaxine—Tachycardia—Triamcinolone—multiple sclerosis	9.64e-05	0.000363	CcSEcCtD
Venlafaxine—SLC6A3—Neuronal System—BCHE—multiple sclerosis	9.64e-05	0.00136	CbGpPWpGaD
Venlafaxine—Nausea—Azathioprine—multiple sclerosis	9.62e-05	0.000363	CcSEcCtD
Venlafaxine—Tachycardia—Methylprednisolone—multiple sclerosis	9.62e-05	0.000363	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9.62e-05	0.00136	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9.62e-05	0.00136	CbGpPWpGaD
Venlafaxine—Erythema—Prednisone—multiple sclerosis	9.57e-05	0.00036	CcSEcCtD
Venlafaxine—Hyperhidrosis—Triamcinolone—multiple sclerosis	9.55e-05	0.00036	CcSEcCtD
Venlafaxine—Agranulocytosis—Methotrexate—multiple sclerosis	9.55e-05	0.00036	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	9.53e-05	0.000359	CcSEcCtD
Venlafaxine—Convulsion—Betamethasone—multiple sclerosis	9.52e-05	0.000359	CcSEcCtD
Venlafaxine—Convulsion—Dexamethasone—multiple sclerosis	9.52e-05	0.000359	CcSEcCtD
Venlafaxine—Hypertension—Dexamethasone—multiple sclerosis	9.48e-05	0.000357	CcSEcCtD
Venlafaxine—Hypertension—Betamethasone—multiple sclerosis	9.48e-05	0.000357	CcSEcCtD
Venlafaxine—Asthenia—Mitoxantrone—multiple sclerosis	9.4e-05	0.000354	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	9.36e-05	0.00132	CbGpPWpGaD
Venlafaxine—Myalgia—Betamethasone—multiple sclerosis	9.35e-05	0.000352	CcSEcCtD
Venlafaxine—Myalgia—Dexamethasone—multiple sclerosis	9.35e-05	0.000352	CcSEcCtD
Venlafaxine—Anxiety—Dexamethasone—multiple sclerosis	9.32e-05	0.000351	CcSEcCtD
Venlafaxine—Anxiety—Betamethasone—multiple sclerosis	9.32e-05	0.000351	CcSEcCtD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.31e-05	0.00132	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CCL5—multiple sclerosis	9.31e-05	0.00132	CbGpPWpGaD
Venlafaxine—Discomfort—Dexamethasone—multiple sclerosis	9.24e-05	0.000348	CcSEcCtD
Venlafaxine—Discomfort—Betamethasone—multiple sclerosis	9.24e-05	0.000348	CcSEcCtD
Venlafaxine—Haemoglobin—Methotrexate—multiple sclerosis	9.23e-05	0.000348	CcSEcCtD
Venlafaxine—Hypotension—Methylprednisolone—multiple sclerosis	9.21e-05	0.000347	CcSEcCtD
Venlafaxine—Pain—Prednisolone—multiple sclerosis	9.19e-05	0.000346	CcSEcCtD
Venlafaxine—Haemorrhage—Methotrexate—multiple sclerosis	9.18e-05	0.000346	CcSEcCtD
Venlafaxine—Hepatitis—Methotrexate—multiple sclerosis	9.18e-05	0.000346	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	9.15e-05	0.00129	CbGpPWpGaD
Venlafaxine—Pharyngitis—Methotrexate—multiple sclerosis	9.12e-05	0.000343	CcSEcCtD
Venlafaxine—Vision blurred—Prednisone—multiple sclerosis	9.02e-05	0.00034	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	9e-05	0.000339	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.98e-05	0.000338	CcSEcCtD
Venlafaxine—Oedema—Betamethasone—multiple sclerosis	8.97e-05	0.000338	CcSEcCtD
Venlafaxine—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.97e-05	0.000338	CcSEcCtD
Venlafaxine—Anaphylactic shock—Betamethasone—multiple sclerosis	8.97e-05	0.000338	CcSEcCtD
Venlafaxine—Oedema—Dexamethasone—multiple sclerosis	8.97e-05	0.000338	CcSEcCtD
Venlafaxine—Diarrhoea—Mitoxantrone—multiple sclerosis	8.96e-05	0.000338	CcSEcCtD
Venlafaxine—Insomnia—Triamcinolone—multiple sclerosis	8.94e-05	0.000337	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.93e-05	0.00126	CbGpPWpGaD
Venlafaxine—Insomnia—Methylprednisolone—multiple sclerosis	8.92e-05	0.000336	CcSEcCtD
Venlafaxine—Infection—Betamethasone—multiple sclerosis	8.91e-05	0.000336	CcSEcCtD
Venlafaxine—Infection—Dexamethasone—multiple sclerosis	8.91e-05	0.000336	CcSEcCtD
Venlafaxine—Ill-defined disorder—Prednisone—multiple sclerosis	8.88e-05	0.000334	CcSEcCtD
Venlafaxine—Paraesthesia—Triamcinolone—multiple sclerosis	8.87e-05	0.000334	CcSEcCtD
Venlafaxine—Feeling abnormal—Prednisolone—multiple sclerosis	8.85e-05	0.000334	CcSEcCtD
Venlafaxine—Paraesthesia—Methylprednisolone—multiple sclerosis	8.85e-05	0.000334	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—multiple sclerosis	8.85e-05	0.000333	CcSEcCtD
Venlafaxine—Anaemia—Prednisone—multiple sclerosis	8.84e-05	0.000333	CcSEcCtD
Venlafaxine—Shock—Dexamethasone—multiple sclerosis	8.82e-05	0.000332	CcSEcCtD
Venlafaxine—Shock—Betamethasone—multiple sclerosis	8.82e-05	0.000332	CcSEcCtD
Venlafaxine—Dyspnoea—Triamcinolone—multiple sclerosis	8.81e-05	0.000332	CcSEcCtD
Venlafaxine—Agitation—Prednisone—multiple sclerosis	8.79e-05	0.000331	CcSEcCtD
Venlafaxine—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.78e-05	0.000331	CcSEcCtD
Venlafaxine—Thrombocytopenia—Betamethasone—multiple sclerosis	8.78e-05	0.000331	CcSEcCtD
Venlafaxine—Tachycardia—Betamethasone—multiple sclerosis	8.75e-05	0.00033	CcSEcCtD
Venlafaxine—Tachycardia—Dexamethasone—multiple sclerosis	8.75e-05	0.00033	CcSEcCtD
Venlafaxine—Angioedema—Prednisone—multiple sclerosis	8.74e-05	0.000329	CcSEcCtD
Venlafaxine—Dyspepsia—Triamcinolone—multiple sclerosis	8.7e-05	0.000328	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—multiple sclerosis	8.68e-05	0.000327	CcSEcCtD
Venlafaxine—Dyspepsia—Methylprednisolone—multiple sclerosis	8.68e-05	0.000327	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.68e-05	0.00123	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.67e-05	0.000327	CcSEcCtD
Venlafaxine—Hyperhidrosis—Betamethasone—multiple sclerosis	8.67e-05	0.000327	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.66e-05	0.00123	CbGpPWpGaD
Venlafaxine—Malaise—Prednisone—multiple sclerosis	8.63e-05	0.000325	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.62e-05	0.00122	CbGpPWpGaD
Venlafaxine—Vertigo—Prednisone—multiple sclerosis	8.6e-05	0.000324	CcSEcCtD
Venlafaxine—Syncope—Prednisone—multiple sclerosis	8.58e-05	0.000323	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.57e-05	0.00121	CbGpPWpGaD
Venlafaxine—Tinnitus—Methotrexate—multiple sclerosis	8.56e-05	0.000323	CcSEcCtD
Venlafaxine—Anorexia—Dexamethasone—multiple sclerosis	8.55e-05	0.000322	CcSEcCtD
Venlafaxine—Anorexia—Betamethasone—multiple sclerosis	8.55e-05	0.000322	CcSEcCtD
Venlafaxine—Urticaria—Prednisolone—multiple sclerosis	8.54e-05	0.000322	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—multiple sclerosis	8.52e-05	0.000321	CcSEcCtD
Venlafaxine—Fatigue—Triamcinolone—multiple sclerosis	8.52e-05	0.000321	CcSEcCtD
Venlafaxine—Fatigue—Methylprednisolone—multiple sclerosis	8.5e-05	0.00032	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.48e-05	0.0012	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL5—multiple sclerosis	8.45e-05	0.0012	CbGpPWpGaD
Venlafaxine—Pain—Triamcinolone—multiple sclerosis	8.45e-05	0.000318	CcSEcCtD
Venlafaxine—Loss of consciousness—Prednisone—multiple sclerosis	8.41e-05	0.000317	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR5—multiple sclerosis	8.38e-05	0.00119	CbGpPWpGaD
Venlafaxine—Hypotension—Betamethasone—multiple sclerosis	8.38e-05	0.000316	CcSEcCtD
Venlafaxine—Hypotension—Dexamethasone—multiple sclerosis	8.38e-05	0.000316	CcSEcCtD
Venlafaxine—Vomiting—Mitoxantrone—multiple sclerosis	8.33e-05	0.000314	CcSEcCtD
Venlafaxine—Convulsion—Prednisone—multiple sclerosis	8.29e-05	0.000312	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2RA—multiple sclerosis	8.26e-05	0.00117	CbGpPWpGaD
Venlafaxine—Hypertension—Prednisone—multiple sclerosis	8.26e-05	0.000311	CcSEcCtD
Venlafaxine—Rash—Mitoxantrone—multiple sclerosis	8.26e-05	0.000311	CcSEcCtD
Venlafaxine—Dermatitis—Mitoxantrone—multiple sclerosis	8.25e-05	0.000311	CcSEcCtD
Venlafaxine—Chills—Methotrexate—multiple sclerosis	8.24e-05	0.00031	CcSEcCtD
Venlafaxine—Headache—Mitoxantrone—multiple sclerosis	8.21e-05	0.000309	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	8.17e-05	0.000308	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	8.17e-05	0.000308	CcSEcCtD
Venlafaxine—Myalgia—Prednisone—multiple sclerosis	8.15e-05	0.000307	CcSEcCtD
Venlafaxine—Arthralgia—Prednisone—multiple sclerosis	8.15e-05	0.000307	CcSEcCtD
Venlafaxine—Feeling abnormal—Triamcinolone—multiple sclerosis	8.14e-05	0.000307	CcSEcCtD
Venlafaxine—Feeling abnormal—Methylprednisolone—multiple sclerosis	8.12e-05	0.000306	CcSEcCtD
Venlafaxine—Anxiety—Prednisone—multiple sclerosis	8.12e-05	0.000306	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—multiple sclerosis	8.12e-05	0.000306	CcSEcCtD
Venlafaxine—Insomnia—Betamethasone—multiple sclerosis	8.11e-05	0.000306	CcSEcCtD
Venlafaxine—Insomnia—Dexamethasone—multiple sclerosis	8.11e-05	0.000306	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	8.06e-05	0.000304	CcSEcCtD
Venlafaxine—Paraesthesia—Dexamethasone—multiple sclerosis	8.05e-05	0.000303	CcSEcCtD
Venlafaxine—Paraesthesia—Betamethasone—multiple sclerosis	8.05e-05	0.000303	CcSEcCtD
Venlafaxine—Discomfort—Prednisone—multiple sclerosis	8.05e-05	0.000303	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—multiple sclerosis	8e-05	0.000301	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.98e-05	0.00113	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisolone—multiple sclerosis	7.92e-05	0.000298	CcSEcCtD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.91e-05	0.00112	CbGpPWpGaD
Venlafaxine—Dyspepsia—Betamethasone—multiple sclerosis	7.89e-05	0.000297	CcSEcCtD
Venlafaxine—Dyspepsia—Dexamethasone—multiple sclerosis	7.89e-05	0.000297	CcSEcCtD
Venlafaxine—Urticaria—Triamcinolone—multiple sclerosis	7.85e-05	0.000296	CcSEcCtD
Venlafaxine—Urticaria—Methylprednisolone—multiple sclerosis	7.83e-05	0.000295	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—multiple sclerosis	7.83e-05	0.000295	CcSEcCtD
Venlafaxine—Body temperature increased—Triamcinolone—multiple sclerosis	7.81e-05	0.000294	CcSEcCtD
Venlafaxine—Anaphylactic shock—Prednisone—multiple sclerosis	7.81e-05	0.000294	CcSEcCtD
Venlafaxine—Oedema—Prednisone—multiple sclerosis	7.81e-05	0.000294	CcSEcCtD
Venlafaxine—Abdominal pain—Methylprednisolone—multiple sclerosis	7.79e-05	0.000294	CcSEcCtD
Venlafaxine—Decreased appetite—Betamethasone—multiple sclerosis	7.79e-05	0.000294	CcSEcCtD
Venlafaxine—Decreased appetite—Dexamethasone—multiple sclerosis	7.79e-05	0.000294	CcSEcCtD
Venlafaxine—Nausea—Mitoxantrone—multiple sclerosis	7.78e-05	0.000293	CcSEcCtD
Venlafaxine—Infection—Prednisone—multiple sclerosis	7.76e-05	0.000292	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.74e-05	0.0011	CbGpPWpGaD
Venlafaxine—Back pain—Methotrexate—multiple sclerosis	7.73e-05	0.000291	CcSEcCtD
Venlafaxine—Fatigue—Betamethasone—multiple sclerosis	7.73e-05	0.000291	CcSEcCtD
Venlafaxine—Fatigue—Dexamethasone—multiple sclerosis	7.73e-05	0.000291	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	7.73e-05	0.00109	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL3—multiple sclerosis	7.72e-05	0.00109	CbGpPWpGaD
Venlafaxine—Shock—Prednisone—multiple sclerosis	7.68e-05	0.000289	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.68e-05	0.00109	CbGpPWpGaD
Venlafaxine—Pain—Betamethasone—multiple sclerosis	7.67e-05	0.000289	CcSEcCtD
Venlafaxine—Pain—Dexamethasone—multiple sclerosis	7.67e-05	0.000289	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.66e-05	0.00108	CbGpPWpGaD
Venlafaxine—Tachycardia—Prednisone—multiple sclerosis	7.62e-05	0.000287	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCR5—multiple sclerosis	7.61e-05	0.00108	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Prednisone—multiple sclerosis	7.55e-05	0.000284	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—multiple sclerosis	7.54e-05	0.000284	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—IL2RA—multiple sclerosis	7.5e-05	0.00106	CbGpPWpGaD
Venlafaxine—Anorexia—Prednisone—multiple sclerosis	7.44e-05	0.00028	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PTGER4—multiple sclerosis	7.43e-05	0.00105	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Methotrexate—multiple sclerosis	7.42e-05	0.000279	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—multiple sclerosis	7.39e-05	0.000278	CcSEcCtD
Venlafaxine—Feeling abnormal—Betamethasone—multiple sclerosis	7.39e-05	0.000278	CcSEcCtD
Venlafaxine—Feeling abnormal—Dexamethasone—multiple sclerosis	7.39e-05	0.000278	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Betamethasone—multiple sclerosis	7.33e-05	0.000276	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	7.33e-05	0.000276	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PGR—multiple sclerosis	7.32e-05	0.00104	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Triamcinolone—multiple sclerosis	7.28e-05	0.000274	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—SRM—multiple sclerosis	7.28e-05	0.00103	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.26e-05	0.000274	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—multiple sclerosis	7.21e-05	0.000272	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—multiple sclerosis	7.18e-05	0.000271	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCR3—multiple sclerosis	7.17e-05	0.00102	CbGpPWpGaD
Venlafaxine—Leukopenia—Methotrexate—multiple sclerosis	7.16e-05	0.00027	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.15e-05	0.00101	CbGpPWpGaD
Venlafaxine—Urticaria—Betamethasone—multiple sclerosis	7.12e-05	0.000268	CcSEcCtD
Venlafaxine—Urticaria—Dexamethasone—multiple sclerosis	7.12e-05	0.000268	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.11e-05	0.000268	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CD28—multiple sclerosis	7.11e-05	0.00101	CbGpPWpGaD
Venlafaxine—Dizziness—Prednisolone—multiple sclerosis	7.11e-05	0.000268	CcSEcCtD
Venlafaxine—Asthenia—Triamcinolone—multiple sclerosis	7.09e-05	0.000267	CcSEcCtD
Venlafaxine—Body temperature increased—Betamethasone—multiple sclerosis	7.09e-05	0.000267	CcSEcCtD
Venlafaxine—Abdominal pain—Betamethasone—multiple sclerosis	7.09e-05	0.000267	CcSEcCtD
Venlafaxine—Abdominal pain—Dexamethasone—multiple sclerosis	7.09e-05	0.000267	CcSEcCtD
Venlafaxine—Body temperature increased—Dexamethasone—multiple sclerosis	7.09e-05	0.000267	CcSEcCtD
Venlafaxine—Asthenia—Methylprednisolone—multiple sclerosis	7.07e-05	0.000266	CcSEcCtD
Venlafaxine—Insomnia—Prednisone—multiple sclerosis	7.06e-05	0.000266	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.06e-05	0.000999	CbGpPWpGaD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.04e-05	0.000996	CbGpPWpGaD
Venlafaxine—Paraesthesia—Prednisone—multiple sclerosis	7.01e-05	0.000264	CcSEcCtD
Venlafaxine—Pruritus—Triamcinolone—multiple sclerosis	6.99e-05	0.000263	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCR2—multiple sclerosis	6.98e-05	0.000988	CbGpPWpGaD
Venlafaxine—Cough—Methotrexate—multiple sclerosis	6.98e-05	0.000263	CcSEcCtD
Venlafaxine—Pruritus—Methylprednisolone—multiple sclerosis	6.98e-05	0.000263	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—multiple sclerosis	6.93e-05	0.000261	CcSEcCtD
Venlafaxine—Dyspepsia—Prednisone—multiple sclerosis	6.87e-05	0.000259	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—multiple sclerosis	6.81e-05	0.000256	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—multiple sclerosis	6.81e-05	0.000256	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—multiple sclerosis	6.81e-05	0.000256	CcSEcCtD
Venlafaxine—Decreased appetite—Prednisone—multiple sclerosis	6.79e-05	0.000256	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.79e-05	0.00096	CbGpPWpGaD
Venlafaxine—Rash—Prednisolone—multiple sclerosis	6.78e-05	0.000255	CcSEcCtD
Venlafaxine—Dermatitis—Prednisolone—multiple sclerosis	6.77e-05	0.000255	CcSEcCtD
Venlafaxine—Diarrhoea—Methylprednisolone—multiple sclerosis	6.75e-05	0.000254	CcSEcCtD
Venlafaxine—Fatigue—Prednisone—multiple sclerosis	6.73e-05	0.000254	CcSEcCtD
Venlafaxine—Headache—Prednisolone—multiple sclerosis	6.73e-05	0.000254	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—multiple sclerosis	6.73e-05	0.000253	CcSEcCtD
Venlafaxine—Constipation—Prednisone—multiple sclerosis	6.68e-05	0.000252	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—multiple sclerosis	6.58e-05	0.000248	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—POMC—multiple sclerosis	6.55e-05	0.000927	CbGpPWpGaD
Venlafaxine—Dizziness—Triamcinolone—multiple sclerosis	6.53e-05	0.000246	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—multiple sclerosis	6.53e-05	0.000246	CcSEcCtD
Venlafaxine—Dizziness—Methylprednisolone—multiple sclerosis	6.52e-05	0.000246	CcSEcCtD
Venlafaxine—Infection—Methotrexate—multiple sclerosis	6.48e-05	0.000244	CcSEcCtD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.47e-05	0.000916	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CNR1—multiple sclerosis	6.44e-05	0.000912	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Prednisone—multiple sclerosis	6.43e-05	0.000242	CcSEcCtD
Venlafaxine—Asthenia—Dexamethasone—multiple sclerosis	6.43e-05	0.000242	CcSEcCtD
Venlafaxine—Asthenia—Betamethasone—multiple sclerosis	6.43e-05	0.000242	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.42e-05	0.000908	CbGpPWpGaD
Venlafaxine—Thrombocytopenia—Methotrexate—multiple sclerosis	6.39e-05	0.000241	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Prednisone—multiple sclerosis	6.38e-05	0.000241	CcSEcCtD
Venlafaxine—Nausea—Prednisolone—multiple sclerosis	6.38e-05	0.00024	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.38e-05	0.000903	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.38e-05	0.000903	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.37e-05	0.000902	CbGpPWpGaD
Venlafaxine—Pruritus—Betamethasone—multiple sclerosis	6.34e-05	0.000239	CcSEcCtD
Venlafaxine—Pruritus—Dexamethasone—multiple sclerosis	6.34e-05	0.000239	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	6.33e-05	0.000896	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Methotrexate—multiple sclerosis	6.31e-05	0.000238	CcSEcCtD
Venlafaxine—Vomiting—Triamcinolone—multiple sclerosis	6.28e-05	0.000237	CcSEcCtD
Venlafaxine—Vomiting—Methylprednisolone—multiple sclerosis	6.27e-05	0.000236	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.24e-05	0.000883	CbGpPWpGaD
Venlafaxine—Rash—Triamcinolone—multiple sclerosis	6.23e-05	0.000235	CcSEcCtD
Venlafaxine—Dermatitis—Triamcinolone—multiple sclerosis	6.22e-05	0.000235	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—multiple sclerosis	6.22e-05	0.000234	CcSEcCtD
Venlafaxine—Rash—Methylprednisolone—multiple sclerosis	6.22e-05	0.000234	CcSEcCtD
Venlafaxine—Dermatitis—Methylprednisolone—multiple sclerosis	6.21e-05	0.000234	CcSEcCtD
Venlafaxine—Urticaria—Prednisone—multiple sclerosis	6.2e-05	0.000234	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.19e-05	0.000877	CbGpPWpGaD
Venlafaxine—Headache—Triamcinolone—multiple sclerosis	6.19e-05	0.000233	CcSEcCtD
Venlafaxine—Headache—Methylprednisolone—multiple sclerosis	6.18e-05	0.000233	CcSEcCtD
Venlafaxine—Body temperature increased—Prednisone—multiple sclerosis	6.17e-05	0.000233	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—multiple sclerosis	6.17e-05	0.000233	CcSEcCtD
Venlafaxine—Diarrhoea—Dexamethasone—multiple sclerosis	6.13e-05	0.000231	CcSEcCtD
Venlafaxine—Diarrhoea—Betamethasone—multiple sclerosis	6.13e-05	0.000231	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—multiple sclerosis	6.1e-05	0.00023	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—POMC—multiple sclerosis	5.95e-05	0.000842	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.95e-05	0.000224	CcSEcCtD
Venlafaxine—Dizziness—Betamethasone—multiple sclerosis	5.93e-05	0.000223	CcSEcCtD
Venlafaxine—Dizziness—Dexamethasone—multiple sclerosis	5.93e-05	0.000223	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—multiple sclerosis	5.9e-05	0.000222	CcSEcCtD
Venlafaxine—Nausea—Triamcinolone—multiple sclerosis	5.87e-05	0.000221	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—multiple sclerosis	5.86e-05	0.000221	CcSEcCtD
Venlafaxine—Nausea—Methylprednisolone—multiple sclerosis	5.86e-05	0.000221	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCL2—multiple sclerosis	5.82e-05	0.000824	CbGpPWpGaD
Venlafaxine—Dyspnoea—Methotrexate—multiple sclerosis	5.82e-05	0.000219	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.82e-05	0.000823	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.82e-05	0.000823	CbGpPWpGaD
Venlafaxine—Somnolence—Methotrexate—multiple sclerosis	5.8e-05	0.000219	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCL10—multiple sclerosis	5.8e-05	0.000821	CbGpPWpGaD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.76e-05	0.000815	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisone—multiple sclerosis	5.75e-05	0.000217	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—multiple sclerosis	5.74e-05	0.000216	CcSEcCtD
Venlafaxine—Vomiting—Dexamethasone—multiple sclerosis	5.7e-05	0.000215	CcSEcCtD
Venlafaxine—Vomiting—Betamethasone—multiple sclerosis	5.7e-05	0.000215	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—multiple sclerosis	5.67e-05	0.000214	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.66e-05	0.0008	CbGpPWpGaD
Venlafaxine—Rash—Betamethasone—multiple sclerosis	5.65e-05	0.000213	CcSEcCtD
Venlafaxine—Rash—Dexamethasone—multiple sclerosis	5.65e-05	0.000213	CcSEcCtD
Venlafaxine—Dermatitis—Betamethasone—multiple sclerosis	5.65e-05	0.000213	CcSEcCtD
Venlafaxine—Dermatitis—Dexamethasone—multiple sclerosis	5.65e-05	0.000213	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—multiple sclerosis	5.63e-05	0.000212	CcSEcCtD
Venlafaxine—Headache—Betamethasone—multiple sclerosis	5.62e-05	0.000212	CcSEcCtD
Venlafaxine—Headache—Dexamethasone—multiple sclerosis	5.62e-05	0.000212	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.61e-05	0.000794	CbGpPWpGaD
Venlafaxine—Asthenia—Prednisone—multiple sclerosis	5.6e-05	0.000211	CcSEcCtD
Venlafaxine—Pain—Methotrexate—multiple sclerosis	5.58e-05	0.00021	CcSEcCtD
Venlafaxine—Pruritus—Prednisone—multiple sclerosis	5.52e-05	0.000208	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	5.45e-05	0.000771	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.43e-05	0.000768	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Methotrexate—multiple sclerosis	5.38e-05	0.000203	CcSEcCtD
Venlafaxine—Diarrhoea—Prednisone—multiple sclerosis	5.34e-05	0.000201	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—SRM—multiple sclerosis	5.34e-05	0.000755	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.34e-05	0.000201	CcSEcCtD
Venlafaxine—Nausea—Betamethasone—multiple sclerosis	5.33e-05	0.000201	CcSEcCtD
Venlafaxine—Nausea—Dexamethasone—multiple sclerosis	5.33e-05	0.000201	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—TYK2—multiple sclerosis	5.29e-05	0.000748	CbGpPWpGaD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.22e-05	0.000739	CbGpPWpGaD
Venlafaxine—Urticaria—Methotrexate—multiple sclerosis	5.18e-05	0.000195	CcSEcCtD
Venlafaxine—Dizziness—Prednisone—multiple sclerosis	5.16e-05	0.000195	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—multiple sclerosis	5.16e-05	0.000194	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—multiple sclerosis	5.16e-05	0.000194	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	5.13e-05	0.000726	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	5.13e-05	0.000726	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CD86—multiple sclerosis	5.07e-05	0.000718	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.04e-05	0.000714	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.03e-05	0.000711	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL5—multiple sclerosis	4.99e-05	0.000707	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.97e-05	0.000704	CbGpPWpGaD
Venlafaxine—Vomiting—Prednisone—multiple sclerosis	4.96e-05	0.000187	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.95e-05	0.0007	CbGpPWpGaD
Venlafaxine—Rash—Prednisone—multiple sclerosis	4.92e-05	0.000185	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—multiple sclerosis	4.92e-05	0.000185	CcSEcCtD
Venlafaxine—Headache—Prednisone—multiple sclerosis	4.89e-05	0.000184	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—multiple sclerosis	4.84e-05	0.000686	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.83e-05	0.000683	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	4.82e-05	0.000683	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Methotrexate—multiple sclerosis	4.81e-05	0.000181	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.81e-05	0.00068	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GPC5—multiple sclerosis	4.69e-05	0.000664	CbGpPWpGaD
Venlafaxine—Asthenia—Methotrexate—multiple sclerosis	4.68e-05	0.000176	CcSEcCtD
Venlafaxine—Nausea—Prednisone—multiple sclerosis	4.64e-05	0.000175	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SPP1—multiple sclerosis	4.62e-05	0.000654	CbGpPWpGaD
Venlafaxine—Pruritus—Methotrexate—multiple sclerosis	4.62e-05	0.000174	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.53e-05	0.000641	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCR5—multiple sclerosis	4.5e-05	0.000637	CbGpPWpGaD
Venlafaxine—Diarrhoea—Methotrexate—multiple sclerosis	4.46e-05	0.000168	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—IL2RA—multiple sclerosis	4.43e-05	0.000627	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—multiple sclerosis	4.4e-05	0.000623	CbGpPWpGaD
Venlafaxine—Dizziness—Methotrexate—multiple sclerosis	4.32e-05	0.000163	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.25e-05	0.000602	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.23e-05	0.000599	CbGpPWpGaD
Venlafaxine—Vomiting—Methotrexate—multiple sclerosis	4.15e-05	0.000156	CcSEcCtD
Venlafaxine—Rash—Methotrexate—multiple sclerosis	4.11e-05	0.000155	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—multiple sclerosis	4.11e-05	0.000155	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—APOE—multiple sclerosis	4.09e-05	0.000579	CbGpPWpGaD
Venlafaxine—Headache—Methotrexate—multiple sclerosis	4.09e-05	0.000154	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.03e-05	0.000571	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SRM—multiple sclerosis	3.94e-05	0.000557	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.92e-05	0.000555	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—RRM1—multiple sclerosis	3.89e-05	0.00055	CbGpPWpGaD
Venlafaxine—Nausea—Methotrexate—multiple sclerosis	3.88e-05	0.000146	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.82e-05	0.00054	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.76e-05	0.000532	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.76e-05	0.000532	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.74e-05	0.000529	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SRM—multiple sclerosis	3.71e-05	0.000525	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CD80—multiple sclerosis	3.7e-05	0.000524	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	3.7e-05	0.000523	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.68e-05	0.000521	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SRM—multiple sclerosis	3.68e-05	0.00052	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.66e-05	0.000518	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—POMC—multiple sclerosis	3.51e-05	0.000498	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL2—multiple sclerosis	3.44e-05	0.000487	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.44e-05	0.000487	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.44e-05	0.000487	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.000482	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.37e-05	0.000477	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—MAPK1—multiple sclerosis	3.36e-05	0.000476	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TYK2—multiple sclerosis	3.12e-05	0.000442	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.85e-05	0.000403	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.84e-05	0.000402	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.84e-05	0.000402	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	2.82e-05	0.000399	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.78e-05	0.000393	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.77e-05	0.000393	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.77e-05	0.000393	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.76e-05	0.00039	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.61e-05	0.00037	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.61e-05	0.00037	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.6e-05	0.000368	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—multiple sclerosis	2.6e-05	0.000368	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.000367	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.000367	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—multiple sclerosis	2.59e-05	0.000366	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GPC5—multiple sclerosis	2.54e-05	0.000359	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.53e-05	0.000358	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—multiple sclerosis	2.46e-05	0.000348	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.44e-05	0.000346	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.43e-05	0.000343	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.39e-05	0.000338	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000335	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.25e-05	0.000318	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.25e-05	0.000318	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—BCHE—multiple sclerosis	2.23e-05	0.000316	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—multiple sclerosis	2.19e-05	0.00031	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.15e-05	0.000305	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—RRM1—multiple sclerosis	2.1e-05	0.000297	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—multiple sclerosis	2.03e-05	0.000288	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TGFB1—multiple sclerosis	2.03e-05	0.000287	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK1—multiple sclerosis	1.99e-05	0.000281	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.00028	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.000278	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.94e-05	0.000274	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.93e-05	0.000274	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.9e-05	0.000269	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.81e-05	0.000256	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000242	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000242	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.67e-05	0.000236	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000232	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.56e-05	0.000221	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—multiple sclerosis	1.53e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.52e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-05	0.000203	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—APOE—multiple sclerosis	1.34e-05	0.00019	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.000185	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.31e-05	0.000185	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000183	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.000175	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.21e-05	0.000172	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.000171	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-05	0.000169	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000163	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000161	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.00016	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000149	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—APOE—multiple sclerosis	9.85e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—POMC—multiple sclerosis	8.46e-06	0.00012	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALB—multiple sclerosis	7.71e-06	0.000109	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APOE—multiple sclerosis	7.44e-06	0.000105	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.44e-06	0.000105	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—APOE—multiple sclerosis	7.26e-06	0.000103	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APOE—multiple sclerosis	6.84e-06	9.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APOE—multiple sclerosis	6.78e-06	9.6e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.39e-06	9.05e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—POMC—multiple sclerosis	6.24e-06	8.83e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—POMC—multiple sclerosis	5.88e-06	8.32e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—POMC—multiple sclerosis	5.83e-06	8.25e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALB—multiple sclerosis	5.83e-06	8.25e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALB—multiple sclerosis	5.69e-06	8.05e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALB—multiple sclerosis	5.36e-06	7.59e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALB—multiple sclerosis	5.31e-06	7.52e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.47e-06	6.33e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.84e-06	5.44e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.5e-06	4.96e-05	CbGpPWpGaD
